Zimmer Biomet (ZBH) Stock Forecast & Price Target

→ A new way to collect income from stocks (From DTI) (Ad)

$121.30

-0.77 (-0.63%)

(As of 04/17/2024 ET)

Zimmer Biomet Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 15 Analyst Ratings

Analysts' Consensus Price Target

$139.39
14.91% Upside

High Forecast	$172.00
Average Forecast	$139.39
Low Forecast	$120.00

Type	Current Forecast 4/18/23 to 4/17/24	1 Month Ago 3/19/23 to 3/18/24	3 Months Ago 1/18/23 to 1/18/24	1 Year Ago 4/18/22 to 4/18/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	6 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$139.39	$137.84	$137.60	$134.19
Predicted Upside	14.91% Upside	12.32% Upside	12.93% Upside	7.74% Upside

Get Zimmer Biomet Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

ZBH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ZBH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Zimmer Biomet Stock vs. The Competition

Type	Zimmer Biomet	Medical Companies	S&P 500
Consensus Rating Score	2.27	2.68	2.49
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	14.86% Upside	923.17% Upside	12.15% Upside
News Sentiment Rating	Positive News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
4/4/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	In-Line ➝ In-Line	$125.00 ➝ $130.00	+0.36%
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$134.00 ➝ $140.00	+8.12%
2/23/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$130.00	+0.61%
2/12/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Underweight ➝ Underweight	$120.00 ➝ $130.00	+3.83%
2/9/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold ➝ Hold	$133.00 ➝ $135.00	+9.93%
2/9/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$115.00 ➝ $125.00	+1.90%
Get the Latest News and Ratings for ZBH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.
2/9/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$140.00	+15.14%
1/3/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$133.00 ➝ $137.00	+13.70%
12/4/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$120.00 ➝ $125.00	+6.56%
11/13/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Market Outperform ➝ Market Outperform	$160.00 ➝ $140.00	+31.14%
10/20/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$120.00	+14.56%
8/28/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$139.00	+20.62%
8/2/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$157.00	+22.29%
8/2/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$116.00 ➝ $125.00	-3.84%
5/18/2023	22nd Century Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Maintains
5/18/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Maintains
5/18/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$160.00 ➝ $165.00	+22.19%
5/3/2023	58.com Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Maintains
5/3/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$121.00 ➝ $147.00	+4.13%
5/3/2023	FIG Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral
5/3/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Neutral
5/3/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$145.00 ➝ $172.00	+20.27%
5/3/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$136.00 ➝ $152.00	+6.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 08:56 PM ET.

ZBH Price Target - Frequently Asked Questions

What is Zimmer Biomet's consensus rating and price target?: According to the issued ratings of 15 analysts in the last year, the consensus rating for Zimmer Biomet stock is Hold based on the current 1 sell rating, 9 hold ratings and 5 buy ratings for ZBH. The average twelve-month price prediction for Zimmer Biomet is $139.39 with a high price target of $172.00 and a low price target of $120.00. Learn more on ZBH's analyst rating history.
Do Wall Street analysts like Zimmer Biomet more than its competitors?: Analysts like Zimmer Biomet less than other Medical companies. The consensus rating for Zimmer Biomet is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how ZBH compares to other companies.
Does Zimmer Biomet's stock price have much upside?: According to analysts, Zimmer Biomet's stock has a predicted upside of 12.55% based on their 12-month stock forecasts.

What analysts cover Zimmer Biomet?: Zimmer Biomet has been rated by Barclays, Canaccord Genuity Group, Citigroup, Evercore ISI, JPMorgan Chase & Co., Royal Bank of Canada, and Truist Financial in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NYSE:ZBH) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Zimmer Biomet (ZBH) Stock Forecast & Price Target

Zimmer Biomet Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

ZBH Analyst Ratings By Month

ZBH Price Targets by Month

Zimmer Biomet Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

ZBH Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info